Levodopa and the Progression of Parkinson's Disease
Top Cited Papers
- 9 December 2004
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (24) , 2498-2508
- https://doi.org/10.1056/nejmoa033447
Abstract
Despite the known benefit of levodopa in reducing the symptoms of Parkinson's disease, concern has been expressed that its use might hasten neurodegeneration. This study assessed the effect of levodopa on the rate of progression of Parkinson's disease.Keywords
This publication has 33 references indexed in Scilit:
- Levodopa Is Toxic to Dopamine Neurons in an in Vitro but Not an in Vivo Model of Oxidative StressThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Chronic L‐DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6‐OHDA or FeCl3 nigrostriatal lesionsMovement Disorders, 2001
- Is There a Rationale for Neuroprotection Against Dopamine Toxicity in Parkinson's Disease?Cellular and Molecular Neurobiology, 2001
- Parkinson Disease, the Effect of Levodopa, and the ELLDOPA TrialArchives of Neurology, 1999
- Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesionsAnnals of Neurology, 1998
- LevodopaNeurology, 1998
- Levodopa-Induced NeurotoxicityCNS Drugs, 1997
- Is levodopa toxic?Neurology, 1996
- Practice parameters [RETIRED]Neurology, 1993
- Time course of nigrostriatal degeneration in parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1976